Short communication · 29 Aug 2025
CommentaryPublished 29 Apr 2025
Evolving Oncology Endpoints: Beyond Overall Survival
Similar by topic
Review article · 28 Feb 2017
Evaluation of Docetaxel vs. Tamoxifen in Combined Therapies Based on Overall Survival Rate (OSR) Endpoint among Female Breast Cancer Patients
Brief report · 29 Aug 2025
Immuno-Oncology: Evolving Trial Design and Response Assessment
Perspective · 30 Sep 2024
Survival Rates in Oncology: A Decade of Progress and Challenges Ahead
Article · 2014
MM-398 Achieves Primary Endpoint of Overall Survival in Phase III Study in Patients with Gemcitabine Refractory Metastatic Pancreatic Cancer
More from this journal
The newest in Journal of Cancer Clinical Trials.
Article · 26 Oct 2026
Leveraging Artificial Intelligence to Structure Next-Generation Sequencing Data for Precision Oncology Research: A Real-World Pancreatic Ductal Adenocarcinoma Liquid Biopsy Experience
Article · 3 Jul 2026
The Current Status of Adjuvant Chemotherapy for Colorectal Cancer in Japan: A Paradigm Shift from Oral Fluoropyrimidine Monotherapy to Oxaliplatin-Based Regimens
Brief report · 29 Dec 2025
Validating Cancer Biomarkers: Challenges and Precision Medicine
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Cancer Clinical Trials
- SubjectOncology & Cancer
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Kenji Watanabe”

